CytomX Therapeutics Announces Full-Year 2018 Financial Results
Go back to CytomX Therapeutics Announces Full-Year 2018 Financial Results| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.76 | 52 Week High | $24.68 | |||
| Open | $2.80 | 52 Week Low | $9.10 | |||
| Day High | $2.83 | P/E | N/A | |||
| Day Low | $2.74 | EPS | $0.00 | |||
| Volume | 2,330,496 | |||||

